Consolidated Statement of Shareholders' Equity (USD $)	Total	Incuron, LLC [Member]	Panacela [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member] Incuron, LLC [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Accumulated Deficit [Member]	Noncontrolling Interest [Member]	Noncontrolling Interest [Member] Incuron, LLC [Member]	Noncontrolling Interest [Member] Panacela [Member]
Beginning balance at Dec. 31, 2010	$ (12,500,135)			$ 144,796	$ 80,241,717		$ (30,544)	$ (96,053,977)	$ 3,197,873
Beginning balance, shares at Dec. 31, 2010				28,959,176
Issuance of common stock net of offering costs	21,870,362			29,363	21,840,999
Issuance of common stock net of offering costs, shares				5,872,500
Allocation of debt and financing proceeds to fair value of warrants	(2,525,175)				(2,525,175)
Noncontrolling interest capital contribution	176,092	2,340,374	9,000,066			176,092				2,164,282	9,000,066
Stock based compensation	6,658,286			1,544	6,656,742
Stock based compensation, shares				308,850
Exercise of options	532,408			951	531,457
Exercise of options, shares				190,255
Exercise of warrants	1,945,220			1,407	1,943,813
Exercise of warrants, shares				281,411
Net loss	(5,229,725)							(4,013,670)	(1,216,055)
Foreign currency translation	153,815						115,157		38,658
Ending balance at Dec. 31, 2011	22,245,496			178,061	108,865,645		84,613	(100,067,647)	13,184,824
Ending balance, shares at Dec. 31, 2011				35,612,192
Issuance of common stock net of offering costs	15,920,584			42,625	15,877,959
Issuance of common stock net of offering costs, shares				8,525,000
Allocation of debt and financing proceeds to fair value of warrants	(4,521,681)				(4,521,681)
Noncontrolling interest capital contribution	1,081,040	5,893,557				1,081,040				4,812,517
Stock based compensation	2,562,459			2,961	2,559,498
Stock based compensation, shares				592,003
Exercise of options	2,375			6	2,369
Exercise of options, shares				1,250
Net loss	(22,414,640)							(18,234,142)	(4,180,498)
Foreign currency translation	797,558						461,860		335,698
Ending balance at Dec. 31, 2012	20,485,708			223,653	123,864,830		546,473	(118,301,789)	14,152,541
Ending balance, shares at Dec. 31, 2012				44,730,445
Allocation of debt and financing proceeds to fair value of warrants	117,999				117,999
Stock based compensation	1,515,509			2,210	1,513,299
Stock based compensation, shares				441,988
Exercise of options	12,391			48	12,343
Exercise of options, shares	9,681			9,681
Net loss	(20,129,284)							(17,262,877)	(2,866,407)
Foreign currency translation	(421,345)						(239,134)		(182,211)
Ending balance at Dec. 31, 2013	$ 1,580,978			$ 225,911	$ 125,508,471		$ 307,339	$ (135,564,666)	$ 11,103,923
Ending balance, shares at Dec. 31, 2013				45,182,114